ESMO 2017 – Day 2 – Focus

Rafal Dziadziuszko comments on the The Pacific Trial and how Immunotherapy is shaping the landscape in advanced lung cancer. Jonathan Ledermann talks about dosing in ovarian cancer chemo.

Produced by the European Society for Medical Oncology
http://www.esmo.org